Chelation Therapy

The AAFP endorses the 1983 AMA Diagnostic and Therapeutic Assessment of Chelation Therapy which reads as follows.

Chelation therapy with ethylenediaminetetraacetic acid or its sodium salt is not an established treatment for atherosclerotic vascular disease. (B1984) (2013 COD)

These policies are provided only as assistance for physicians making clinical decisions regarding the care of their patients. As such, they cannot substitute for the individual judgment brought to each clinical situation by the patient’s family physician. As with all clinical reference resources, they reflect the best understanding of the science of medicine at the time of publication, but they should be used with the clear understanding that continued research may result in new knowledge and recommendations. These policies are only one element in the complex process of improving the health of America. To be effective, this policy must be implemented.